201
Participants
Start Date
June 13, 2023
Primary Completion Date
October 16, 2024
Study Completion Date
January 7, 2025
ANB032
BTLA agonist antibody
Placebo
Placebo
AnaptysBio Investigative Site 36-101, Grafton
AnaptysBio Investigative Site 57-101, Prague
AnaptysBio Investigative Site 35-103, Woolloongabba
AnaptysBio Investigative Site 35-104, Coorparoo
AnaptysBio Investigative Site 36-103, Wellington
AnaptysBio Investigative Site 36-104, Nelson
AnaptysBio Investigative Site 57-105, Prague
AnaptysBio Investigative Site 57-102, Prague
AnaptysBio Investigative Site 10-145, Philadelphia
AnaptysBio Investigative Site 10-108, Wilmington
AnaptysBio Investigative Site 10-109, Charlotte
AnaptysBio Investigative Site 10-122, Atlanta
AnaptysBio Investigative Site 10-136, Doral
AnaptysBio Investigative Site 10-133, Miami
AnaptysBio Investigative Site 10-116, Miami
AnaptysBio Investigative Site 10-134, Miami
AnaptysBio Investigative Site 10-106, Miami
AnaptysBio Investigative Site 10-119, Nashville
AnaptysBio Investigative Site 10-129, Mason
AnaptysBio Investigative Site 10-149, Merrillville
AnaptysBio Investigative Site 10-127, Clarksville
AnaptysBio Investigative Site 10-128, New Albany
AnaptysBio Investigative Site 10-138, Troy
AnaptysBio Investigative Site 10-126, Ann Arbor
AnaptysBio Investigative Site 10-114, Detroit
AnaptysBio Investigative Site 10-139, Auburn Hills
AnaptysBio Investigative Site 57-104, Pardubice
AnaptysBio Investigative Site 10-151, Flossmoor
AnaptysBio Investigative Site 10-150, Hazelwood
AnaptysBio Investigative Site 10-110, Saint Joseph
AnaptysBio Investigative Site 10-137, Baton Rouge
AnaptysBio Investigative Site 10-105, Frisco
AnaptysBio Investigative Site 10-124, Dallas
AnaptysBio Investigative Site 10-142, Katy
AnaptysBio Investigative Site 10-144, Baytown
AnaptysBio Investigative Site 10-104, San Antonio
AnaptysBio Investigative Site 10-130, Boise
AnaptysBio Investigative Site 10-148, Las Vegas
AnaptysBio Investigative Site 10-112, Santa Monica
AnaptysBio Investigative Site 10-141, Cerritos
AnaptysBio Investigative 10-125, Lomita
AnaptysBio Investigative Site 10-147, Pasadena
AnaptysBio Investigative Site 10-121, Fountain Valley
AnaptysBio Investigative Site 10-140, Anaheim
AnaptysBio Investigative Site 10-146, Oxnard
AnaptysBio Investigative Site 10-120, Lancaster
AnaptysBio Investigative Site 10-107, Fremont
AnaptysBio Investigative Site 10-113, Portland
AnaptysBio Investigative Site 10-132, Spokane
AnaptysBio Investigative Site 10-131, Methuen
AnaptysBio Investigative Site 11-105, Surrey
AnaptysBio Investigative Site 11-102, Barrie
AnaptysBio Investigative Site 11-106, Etobicoke
AnaptysBio Investigative Site 11-101, London
AnaptysBio Investigative Site 11-103, North Bay
AnaptysBio Investigative Site 11-107, Richmond Hill
AnaptysBio Investigative Site 59-105, Tbilisi
AnaptysBio Investigative Site 59-106, Tbilisi
AnaptysBio Investigative Site 59-101, Tbilisi
AnaptysBio Investigative Site 59-102, Tbilisi
AnaptysBio Investigative Site 59-103, Tbilisi
AnaptysBio Investigative Site 59-104, Tbilisi
AnaptysBio Investigative Site 59-107, Tbilisi
AnaptysBio Investigative Site 36-102, Rosedale
AnaptysBio Investigative Site 30-111, Bydgoszcz
AnaptysBio Investigative Site 30-113, Częstochowa
AnaptysBio Investigative Site 30-108, Gdansk
AnaptysBio Investigative Site 30-106, Krakow
AnaptysBio Investigative Site 30-101, Lodz
AnaptysBio Investigative Site 30-109, Rzeszów
AnaptysBio Investigative Site 30-115, Skierniewice
AnaptysBio Investigative Site 30-112, Szczecin
AnaptysBio Investigative Site 30-102, Świdnik
AnaptysBio Investigative Site 30-105, Warsaw
AnaptysBio Investigative Site 30-107, Warsaw
AnaptysBio Investigative Site 30-116, Warsaw
AnaptysBio Investigative Site 30-104, Wroclaw
AnaptysBio Investigative Site 30-114, Wroclaw
Lead Sponsor
AnaptysBio, Inc.
INDUSTRY